Abstract
Our progress in understanding the pathogenesis of human muscular dystrophies has been extremely slow, despite the fact that the majority of such syndromes are inherited diseases, and our general progress in understanding other genetic diseases of man has moved at a rapidly accelerating pace. Such slow progress might be related primarily to our ignorance of the most appropriate biochemical approaches to these problems, but it can also be attributed to a relatively unproductive concentration of research efforts on muscle tissue which has undergone numerous secondary changes. In addition, considerable effort has been invested in experimental models of myotonia and dystrophy which bear only minimal resemblance to the human disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Appel, S. H., and A. D. Roses. 1977. The muscular dystrophies. In: The Metabolic Basis of Inherited Disease, 4th ed. J. B. Stanbury, J. B. Wyngaarden, and D. S. Frederickson, eds. McGraw-Hill, New York. In press.
Kampine, T. P., R. O. Brady, J. N. Kanfer, M. Feld, and D. Shapiro. 1955. Diagnosis of Gaucher’s disease and Niemann-Pick disease with small samples of venous blood. Science 155: 86–88.
Rosenbloom, F. M., W. N. Kelley, J. F. Henderson, and J. E. Seegmiller. 1967. Lyon hypothesis and X- linked disease. Lancet 2: 305–306.
Melunsky, A., J. W. Littlefield, J. N. Kanfer, E. H. Kolodny, V. E. Shih, and L. Atkins. 1970. Prenatal genetic diagnosis. N. Engl. J. Med. 283: 1370–1381.
Layzer, R. B., and J. Rasmussen. 1974. The molecular basis of muscle phosphofructokinase deficiency. Arch. Neurol. 31: 411–417.
Thomasen, E. 1948. Myotonia in Thomsen’s Disease (Myotonia Congenita), Paramyotonia and Dystrophia Myotonia. Universitetsforlaget, Aarhus. 251 pp.
Caughey, J. E., and N. C. Myriathopoulos. 1963. Dystrophia Myotonia and Related Disorders. Thomas, Springfield, Illinois. 282 pp.
Decourt, J. 1966. Les troubles endocrineins de la dystrophic myetonique (Maladie de Steinert). In: Progressive Muskeldystrophie, Myotome, Myasthenie. E. Kuhn, ed. Springer-Verlag, Berlin and New York. pp. 265–280.
Drucker, W. D., L. P. Rowland, K. Sterling, and N. P. Cristy. 1961. On the function of the endocrine glands in myotonic muscular dystrophy. Am. J. Med. 31: 941–950.
Kühl, W. J., I. S. Harper, and R. M. Dowben. 1961. Thyroxine and triiodothyronine turnover studies in dystrophia myotonica. J. Clin. Endocrinol. 31: 1592–1595.
Görden, P., R. C. Griggs, S. R. Nissley, J. Roth, and W. K. Engel. 1969. Studies of plasma insulin in myotonic dystrophy. J. Clin. Endocrinol. 29: 684–690.
Church, S. C. 1967. The heart in myotonia atrophica. Arch. Intern. Med. 119: 176–181.
Bache, R. J., and G. A. Sarosi. 1968. Myotonia atrophica: Diagnosis in patient with complete heart block and Stokes-Adams syncope. Arch. Intern. Med. 121: 369–372.
Kohn, N. H., J. S. Faires, and T. Rodman. 1964. Unusual manifestations due to involvement of involuntary muscle in dystrophia myotonica. N. Engl. J. Med. 271: 1179–1183.
Hughes, D. T. D., J. C. Swann, J. A. Gleeson, and F. I. Lee. 1965. Abnormalities in swallowing associated with dystrophia myotonica. Brain 88: 1037–1042.
Kuhn, V. E., J. Schaaf, W. Wenz, and W. Stein. 1965. Untersuchungen am Verdauungstrokt bei myotonischer dystrophic. Schweiz. Med. Wochenschr. 95: 1263–1266.
Harvey, J. C., D. H. Sherbourne, and C. E. Siegel. 1965. Smooth muscle involvement in myotonic dystrophy. Am. J. Med. 39: 81–90.
Wochner, D. R., G. Drews, W. Strober, and T. A. Waldmann. 1966. Accelerated breakdown of immunoglobulin G (lgG) in myotonic dystrophy: A hereditary error of immunoglobulin catabolism. J. Clin. Invest. 45: 321–329.
Lindsley, D. B., and E. C. Curnen. 1936. An electromyographic study of myotonia. Arch. Neurol. Psychiatry. 35: 253–269.
Denny-Brown, D., and S. Nevin. 1941. The phenomenon of myotonia. Brain 64: 1–18.
Roses, A. D., P. Harper, E. Bossen, 1952. Myotonic muscular dystrophy (dystrophia myotonica, myotonia atrophy). In: Handbook of Clinical Neurology. J. Viken and G. W. Bruyn, eds. Wiley, New York.
Bryant, S. H. 1973. The electrophysiology of myotonia with a review of congenital myotonia of goats. In: New Developments in Electromyography and Clinical Neuro Physiology, Vol. I. J. E. Desmedt, ed. Karger, Basel, pp. 420–450.
Adrian, R. H., and S. H. Bryant. 1974. On the repetitive discharge in myotonic muscle fibers. J. Physiol. 240: 505–515.
Eyzaguirre, C., B. P. Folk, K. L. Zieler, and J. L. Lilienthal. 1948. Experimental myotonia and repetitive phenomena: The veratrinic effects of 2,4-dichlorphen- oxyacetate (2,4-D) in the rat. Am. J. Physiol. 155:69- 77.
Winer, N., D. M. Klachko, R. D. Baer, P. L. Langley, and T. W. Burns. 1966. Myotonia response induced by inhibitors of cholesterol biosynthesis. Science 153: 312–313.
Rudel, R., and J. Senges. 1973. Experimental my-otonia. In: New Developments in Electromyography and Clinical Neurophysiology, Vol. I. J. E. Desmedt, ed. Karger, Basel, pp. 483–491.
Lipicky, R. J. 1977. Studies in human myotonic dystrophy. In: Pathogenesis of Human Muscular Dystrophies, L. P. Rowland, ed. Elsevier, North Holland, New York. pp. 729–738.
McComas, A. J., and K. Mrozek. 1968. The electrical properties of muscle fiber membranes in dystrophic myotonica and myotonia congenita. J. Neurol. Neurosurg. Psychiatry. 31: 441–447.
Hofmann, W. W., W. Alston, and G. Rowe. 1966. A study of individual neuromuscular junctions in myotonia. Electroencephalogr. Clin. Neurophysiol. 21: 521–537.
Roses, A. D., and S. H. Appel. 1973. Protein kinase activity in erythrocyte ghosts of patients with myotonic muscular dystrophy. Proc. Natl. Acad. Sci. U.S.A. 70: 1855–1859.
Roses, A. D., and S. H. Appel. 1975. Phosphorylation of component a of the human erythrocyte membrane in myotonic muscular dystrophy. J. Membr. Biol. 20:51–58.
Andrew, C. G., R. R. Almon, and S. H. Appel. 1975. Macromolecular characterization of muscle mem-branes: Endogenous membrane kinase and phosphorylated protein substrate from normal and denervated muscle. J. Biol. Chem. 250: 3972 – 3980.
Andrew, C. G., and S. H. Appel. 1973. Macromolecular characterization of muscle membranes. I. Proteins and sialic acid of normal and denervated muscle. J. Biol. Chem. 248: 5156–5163.
Roses, A. D., and S. H. Appel. 1974. Muscle mem-brane protein kinase in myotonic muscular dystrophy. Nature 250: 245–247.
Butterfield, D. A., A. D. Roses, M. L. Cooper, S. H. Appel, and D. B. Chesnut. 1974. A comparative ESR study of the erythrocyte membrane in myotonic muscular dystrophy. Biochemistry 13: 5078–5082.
Miller, S. E., A. D. Roses, and S. H. Appel. 1976. Scanning electron microscopy studies in muscular dystrophy. Arch. Neurol. 33: 172–174.
Hofmann, W. W., and G. L. DeNardo. 1968. Sodium flux in myotonic muscular dystrophy. Am. J. Physiol. 214: 330–336.
Hull, K. L., and A. D. Roses. 1976. Stoichiometry of sodium and potassium transport in erythrocytes from patients with myotonic muscular dystrophy. J. Physiol. 254: 169–181.
Gardos, G. 1958. The function of calcium in potassium permeability of human erythrocytes. Biochim. Biophys. Acta 30: 653–654.
Appel, S. H., and A. D. Roses. 1976. Membrane biochemical studies in myotonic muscular dystrophy. In: Membranes and Disease. L. Bolis, J. F. Hoffman, and A. Leaf, eds. Raven Press, New York. pp. 189–195.
Meech, R. W. 1972. Intracellular calcium injection causes increased potassium conductance in Aplysia nerve cells. Comp. Biochem. Physiol. 42a: 493–499.
Meech, R. W. 1974. The sensitivity of Helix aspersa neurons to injected calcium ions. J. Physiol. 237: 259–277.
Meech, R. W. 1974. Calcium influx induces a post- tetanic hyperpolarization in Aplysia neurons. Comp. Biochem. Physiol. 48a: 387–395.
Krnjevic, K., E. Puil, and R. Werman. 1975. Evidence for Ca2+-activated K+ conductance in cat spinal motoneurons from intracellular EGTA injections. Can. J. Physiol. Pharmacol. 53: 1214–1218.
Lassen, U. V., L. Pape, B. Vestergaand-Bogind, and O. Bengtsen. 1974. Calcium-related hyperpolarization of the Amphiuma red cell membrane following micropuncture. J. Membr. Biol. 18: 125–144.
Meech, R. W. 1974. Prolonged action potentials in Aplysia neurons injected with EGTA. Comp. Biochem. Physiol. 48a: 397–402.
Meech, R. W., and N. B. Standen. 1975. Potassium activation in Helix aspersa neurons under voltage clamp: A component mediated by calcium influx. J. Physiol. 249: 211–239.
Samaha, F. J., and J. Gergely. 1969. Biochemical abnormalities of the sarcoplasmic reticulum in muscular dystrophy. N. Engl. J. Med. 280: 184 - 188.
Roses, A. D., M. J. Roses, G. A. Nicholson, and C. R. Roe. 1977. Lactate dehydrogenase isoenzyme 5 (LDH- 5) in Duchenne muscular dystrophy. Neurology 27: 414–421.
Mokri, B., and A. G. Engel. 1975. Duchenne dystrophy: Electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology 25: 1111–1120.
Sugita, H., E. Okimoto, S. Ebashi, and O. Kinaka. 1967. Biochemical alterations in progressive muscular dystrophy with special reference to the sarcoplasmic reticulum. In: Exploratory Concepts in Muscular Dystrophy and Related Disorders. A. T. Milhorat, ed. Excerpta Medica, Amsterdam, pp. 321–326.
Peter, J. B., M. Worsfold, and W. Fiehn. 1974. Kinetic characteristics of fragmented sarcoplasmic reticulum from normal and diseased human skeletal muscle. In: Exploratory Concepts in Muscular Dystrophy II. A. T. Milhorat, ed. Excerpta Medica, Amsterdam, pp. 491–498.
Kunze D., G. Reichmann, E. Egger, G. Leuschner, and H. Eckhardt. 1973. Erythrocytenlipide bei progressive Muskeldystrophie. Clin. Chem. Acta 43: 333–341.
Brown, H. D., S. K. Chattpadhyay, and A. B. Patel. 1967. Erythrocyte abnormality in human myopathy. Science 157: 1577–1578.
Klassen, G. A., and R. Blosteen. 1969. Adenosine triphosphatase and myopathy. Science 163: 492–493.
Peter, J. B., M. Worsfeld, and C. M. Pearson. 1969. Erythrocyte ghost ATPase in Duchenne dystrophy. J. Lab. Clin. Med. 74: 103–108.
Mawatari, S., M. Schonberg, and M. Olarte. 1977. Biochemical abnormalities of erythrocyte membranes in Duchenne dystrophy. Arch. Neurol. 33: 489–493.
Percy, A. K., and M. E. Miller. 1975. Reduced deformability of erythrocyte membranes from patients with Duchenne muscular dystrophy. Nature 258: 147–148.
Roses, A. D., M. H. Herbstreith, and S. H. Appel. 1975. Membrane protein kinase alterations in Duchenne muscular dystrophy. Nature 254: 350–351.
Roses, A. D., and S. H. Appel. 1976. Erythrocyte spectrin peak II phosphorylation in Duchenne muscular dystrophy. J. Neurol. Sci. 29: 185–193.
Roses, A. D., M. H. Herbstreith, B. Metcalf, and S. H. Appel. 1976. Increased phosphorylated components of erythrocyte membrane spectrin band II with reference to Duchenne muscular dystrophy. J. Neurol. Sci. 30: 167–178.
Roses, A. D., M. J. Roses, S. E. Miller, K. L. Hull, Jr., and S. H. Appel. 1976. Carrier detection in Duchenne muscular dystrophy. N. Engl. J. Med. 294: 193–198.
Francke, V., J. Felsensteen, S. M. Gartler, B. R. Migeon, J. Dancis, J. E. Seegmiller, F. Bakay, and W. L. Nyhan. 1976. The occurrence of new mutants in the X-linked recessive Lesch-Nyhan disease. Am. J. Hum. Genet. 28: 123–137.
Guidotti, G. 1972. Membrane proteins. Annu. Rev. Biochem. 41: 731–752.
McPherson, J., C. Fenner, A. Smith, D. T. Mason, and J. Wikman-Coffelt. 1974. Identification of in vivo phos-phorylated myosin subunits. FEBS Lett. 47: 149–154.
Perrie, W. T., L. B. Smillie, and S. V. Perry. 1973. A phosphorylated light-chain component of myosin from skeletal muscle. Biochem. J. 135: 151–164.
Adelstein, R. S., and M. A. Conti. 1975. Phosphorylation of platelet myosin increases actin-activated myosin ATPase activity. Nature 256: 597–598.
Adelstein, R. S., M. A. Conti, and W. Anderson, Jr. 1973. Phosphorylation of human platelet myosin. Proc. Natl. Acad. Sci. U.S.A. 70: 3115–3119.
Adelstein, R. S., and M. A. Conti. 1975. Phosphorylation of platelet myosin increases actin-activated myosin ATPase activity. Nature 256: 597 - 599.
Krebs, E. G., J. A. Beavo, P. J. Bechtel, P. J. England, T. S. Huang, and J. T. Stull. 1974. Cyclic-AMP and protein phosphorylation reactions in muscle. In: Exploratory Concepts in Muscular Dystrophy II. A. T. Milhorat, ed. Excerpta Medica, Amsterdam, pp. 431–448.
Roses, A. D. 1977. Erythrocytes in dystrophies. In: Pathogenesis of Human Dystrophies. Lewis P. Rowland, ed. Excerpta Medica, Amsterdam-Oxford, pp. 648–655.
Lowey, S., H. S. Slayter, A. G. Weeds, and H. Baker. 1969. Structure of the myosin molecule. I. Subfragments of myosin by enzymatic degradation. J. Mol. Biol. 42: 1–29.
Weeds, A. G., and S. Lowey. 1971. Structure of the myosin molecule. II. The light chains of myosin. J. Mol. Biol. 61: 701–725.
Schechter, N. M., M. Sharp, J. A. Reynolds, and C. Tanford. 1976. Erythrocyte spectrin. Purification in deoxycholate and preliminary characterization. Biochemistry 15: 1897–1904.
Gratzer, W. B., and S. Lowey. 1969. Effect of sub-strate on the conformation of myosin. J. Biol. Chem. 244: 22–25.
Gratzer, W. B., and G. H. Beaven. 1975. Properties of the high molecular weight protein (spectrin) from human erythrocyte membranes. Eur. J. Biochem 58: 403–409.
Godfrey, J. E., and W. F. Harrington. 1970. Self- association in the myosin system at high ionic strength. I. Sensitivity of the interaction to pH and ionic environment. Biochemistry 9: 886 - 893.
Langdon, R. G. 1974. Serum lipoprotein apoproteins as major protein constituents of the human erythrocyte membrane. Biochim. Biophys. Acta 342: 213–228.
Bhakdi, S., H. Knufermann, and D. F. H. Wallach. 1974. Separation of EDTA extractable erythrocyte membrane proteins by isoelectric focusing linked to electrophoresis in sodium dodecyl sulfate. Biochim. Biophys. Acta 345: 448–457.
Trayer, I. P., C. I. Harris, and S. V. Perry. 1968. 3- Methyl histidine and adult and foetal forms of skeletal muscle myosin. Nature 217: 452 - 453.
Hardy, M. F., C. I. Harris, S. V. Perry, and D. Stone. 1970. Occurrence and formation of the TV-methyl ly-sines in myosin and the myofibrillar proteins. Biochim. J. 120: 653–660.
Huszar, G. 1972. Developmental changes of the primary structure and histidine methylation in rabbit skeletal muscle myosin. Nature (New Biol.) 240: 260–264.
Rosenthal, A. S., F. M. Kregenow, and H. C. Moses. 1970. Some characteristics of a Ca2+-dependent ATPase activity associated with a group of erythrocyte membrane proteins which form fibrils. Biochim. Biophys. Acta 196: 254–262.
Kirkpatrick, F. H., G. M. Woods, P. L. LaCelle, and R. I. Weed. 1975. Calcium and magnesium ATPases of the spectrin fraction of human erythrocytes. J. Supramol. Struct. 3: 415–425.
Tonomura, Y., and F. Oosawa. 1972. Molecular mechanism of contraction. Annu. Rev. Biophys. and Bioeng. 1: 159–190.
Dreizen, P., and D. H. Richards. 1973. Studies on the role of light and heavy chains in myosin adenosine triphosphatase. Cold Spring Harbor Symp. Quant. Biol. 37: 29–45.
Painter, R. G., M. Sheetz, and S. J. Singer. 1975. Detection and ultrastructural localization of human smooth muscle myosin-like molecules in human non- muscle cells by specific antibodies. Proc. Natl. Acad. Sci. U.S.A. 72: 1359–1363.
Groschel-Stewart, U. 1971. Comparative studies of human smooth and striated muscle myosins. Biochim. Biophys. Acta 229: 322–334.
Pinder, J. C., D. Bray, and W. B. Gratzer. 1975. Actin polymerisation induced by spectrin. Nature 258: 765–766.
Roses, A. D., M. H. Herbstreith, B. S. Metcalf, and G. B. Hartwig. 1977. Biochemical relationships between muscle and erythrocyte membrane: Interpretation with respect to Duchenne muscular dystrophy. In: Contemporary Clinical Neurophysiology (Supplement No. 34 to Electroencephalography and Clinical Neurophysiology). W. A. Cobb and H. Duijn, eds. Elsevier, Amsterdam. In press.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Plenum Publishing Corporation
About this chapter
Cite this chapter
Roses, A.D., Appel, S.H. (1978). Inherited Membrane Disorders of Muscle: Duchenne Muscular Dystrophy and Myotonic Muscular Dystrophy. In: Andreoli, T.E., Hoffman, J.F., Fanestil, D.D. (eds) Physiology of Membrane Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3958-8_38
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3958-8_38
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3960-1
Online ISBN: 978-1-4613-3958-8
eBook Packages: Springer Book Archive